FoodtopsyFrançais
Menu

Kiwifruit allergy

In the body: An allergy is the immune system reacting to the food.

Not rated by dose: a flag on one reviewed food, kiwis.

For some people. Allergies, medicines and medical conditions: a flag for the people the source names, no wider.

All hazards

The reference value and where it comes from

  • The agency’s figureno agency dose value
  • BasisIgE-mediated allergy to kiwifruit proteins (Act d 1 actinidin, Act d 2, 5, 8, 9, 10); person-specific, no dose limit; not a Health Canada priority allergen
  • Average adult intake confirmed prevalence 0.10% in Turkish schoolchildren (Haktanir Abul 2017)
  • Applies topeople sensitised to kiwifruit allergens, to birch or grass pollen or to latex
  • Source PubMed 23141741

Reviewed foods that carry it

1 reviewed food carries it; none is rated by dose.

How often you can eat it

No food here is rated by dose. Each line says why it’s listed: a flag for the people the source names, advice on handling it, or context.

Flags and context, not rated by dose

  • Kiwi, raw

    Worth knowing

    PubMed 23141741 · grade B

    How it’s rated

    Flagged for people with a kiwifruit allergy: an allergy to kiwifruit proteins, not a dose limit. Sensitisation to Act d 1 (actinidin) and living in Iceland were independent risk factors for severe allergy (odds ratio 3.98 and 5.60), though actinidin is not the major allergen everywhere: in 76 UK patients a 38 kDa protein was. Parent-reported prevalence in children in one Turkish city was 0.5% (72 of 15,783 responders), which cannot be applied to Canadian adults. Kiwi is not on Health Canada's priority allergen list, so Canadian labels do not have to declare it.

    Intake: one 140 g serving a day, 70 kg adult · Level in the food: 0.1 % of 6-18-year-old urban schoolchildren with open-challenge-confirmed IgE-mediated kiwifruit allergy (95% CI 0.06-0.16), Rize, Turkey (prevalence, n = 15783)

    Measured on: Population study in a kiwifruit-growing region (parental-perceived prevalence 0.5%, 72 of 15,783 questionnaire responders); EuroPrevall case series (Le 2013) of 311 kiwifruit-allergic patients, 12 countries.

Sources